Related Experiment Video
Updated: Nov 17, 2025

Imaging Dpp Release from a Drosophila Wing Disc
Published on: October 30, 2019
A literature review on function and regulation mechanism of DKK4
Xiaoli Lou1, Yuchen Meng1, Yanqiang Hou1
1Department of Central Laboratory, Songjiang Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Abstract:
Dickkopf-related protein 4 (DKK4) is a member of the dickkopf family and an inhibitor of the Wnt/β-catenin signalling pathway. This review surveyed the single nucleotide polymorphisms (SNPs), copy number variations (CNVs), hypermethylation, regulation mechanism, correlation with clinicopathological parameters and chemotherapeutic resistance of DKK4. The signal pathways involved in DKK4 mainly include Wnt/β-catenin pathway and Wnt-JNK pathway independent β-catenin. DKK4 expression was upregulated in Renal Cell Carcinoma (RCC), Colorectal Cancer, Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC) and Epithelial Ovarian Cancer (EOC), while downregulated in Hepatocellular Carcinoma (HCC). DKK4 is not only involved in tumour growth, invasion, migration and chemotherapy resistance, but also in osteoblastogenesis and secondary hair or meibomian gland formation. DKK4 has also been linked to schizophrenia.
Insights
Dickkopf-related protein 4 (DKK4) is a key regulator of Wnt/β-catenin signaling. This review details DKK4
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Dickkopf-related protein 4 (DKK4) is a member of the dickkopf family.
- DKK4 functions as an inhibitor of the Wnt/β-catenin signaling pathway.
- Aberrant DKK4 expression is implicated in various diseases.
Purpose of the Study:
- To review genetic variations (SNPs, CNVs), epigenetic modifications (hypermethylation), and regulatory mechanisms of DKK4.
- To examine the correlation between DKK4 and clinicopathological parameters, and its role in chemotherapeutic resistance.
- To explore the involvement of DKK4 in diverse biological processes and diseases.
Main Methods:
- Literature review of studies on DKK4.
- Analysis of DKK4's role in Wnt/β-catenin and Wnt-JNK pathways.
- Compilation of data on DKK4 expression patterns in different cancers.
Main Results:
- DKK4 expression is upregulated in Renal Cell Carcinoma (RCC), Colorectal Cancer, Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC), and Epithelial Ovarian Cancer (EOC).
- DKK4 expression is downregulated in Hepatocellular Carcinoma (HCC).
- DKK4 influences tumor growth, invasion, migration, and chemotherapy resistance, as well as osteoblastogenesis, hair, and meibomian gland formation. DKK4 is also linked to schizophrenia.
Conclusions:
- DKK4 is a significant factor in cancer development and progression across multiple tumor types.
- DKK4's multifaceted roles extend beyond cancer to developmental processes and neurological disorders.
- Further research into DKK4's mechanisms could yield novel therapeutic strategies.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
08:11Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
Related Concept Videos
Inhibition of Cdk Activity
Dipeptidyl Peptidase 4 Inhibitors
The JAK-STAT Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Angiogenesis and Blood Supply
Canonical Wnt Signaling Pathway